org placeholder image

Garry Kiefer

CEO, Director of R&D at Macrocyclics

  • LinkedIn

Email Email: g****@macrocyclics.com

phone noPhone Number: (***)-***-****

Dr. Kiefer began his career with the Dow Chemical Company working in Discovery Research where he led in the development of innovative chelation chemistry technologies for diagnostic and t...

Read More

map
MACROCYCLICS

MACROCYCLICS

  • description Description
    Macrocyclics, Inc., a manufacturer of customized chelating agents, is dedicated to leading-edge development of new chelation chemistry platforms critical for advancement of diagnostic and the...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 5 Million to 10 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Macrocyclics Org Chart and Mapping

Employees

Duke Halloran

Production Manager, Business Development Lead

Paul Jurek

Director of Custom Product Development

Frequently Asked Questions Regarding Garry Kiefer

Answer: Garry Kiefer works for Macrocyclics as CEO, Director of R&D

Answer: Garry Kiefer’s role in Macrocyclics is CEO, Director of R&D

Answer: Garry Kiefer's email address is g***@gmail.com

Answer: Garry Kiefer's business email address is g****@macrocyclics.com

Answer: Garry Kiefer’s direct phone number is (***)-***-****

Answer: Garry Kiefer works in the industry of: Biotechnology

Answer: Garry Kiefer is the current CEO, Director of R&D at Macrocyclics.... Read More

Answer: Garry Kiefer works Macrocyclics located at 700 Klein Rd, Plano, Texas, 75074, United States

Answer: Macrocyclics's CEO, Director of R&D is Garry Kiefer

Answer: Garry Kiefer contact details:

  • Phone number  :  (***)-***-****
  • Email  :  g****@macrocyclics.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access